Phathom Pharmaceuticals, Inc. (PHAT) income statement
PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.66−0.42 (-8.27%)
Close on Nov 20, 2026Market cap $378.82MP/E –Yield –
Phathom Pharmaceuticals, Inc. financial ratios
See a number that looks wrong?